(Q48289121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Serotonin in migraine: theories, animal models and emerging therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

0 references

1 reference

K W Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L A Phebus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M L Cohen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

219-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Plasma Serotonin in Migraine and Stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Serotonin metabolism in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Immunohistochemical demonstration of serotonin in nerves supplying human cerebral and mesenteric blood-vessels. Some speculations about their involvement in vascular disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The effects of reserpine injection on methysergide treated control and migrainous subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Focal headache during balloon inflation in the internal carotid and middle cerebral arteries

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Cluster headache: transcranial Doppler ultrasound and rCBF studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Effect of serotonin in migraine patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Cerebral blood flow during migraine attacks without aura and effect of sumatriptan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Blood Flow Velocity Changes in Migraine Attacks-A Transcranial Doppler Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The Effect of Intra-arterial Papaverine on the Regional Cerebral Blood Flow in Patients with Stroke or Intracranial Tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Migraine: a cerebral disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The visceral organ brain: implications for the pathophysiology of vascular head pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Calcitonin gene-related peptide is a potent inhibitor of substance P degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Nitric oxide is a key molecule in migraine and other vascular headaches.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Nitric oxide synthase inhibition in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Nitric oxide: a neural messenger

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Anti-migraine drugs in development: advances in serotonin receptor pharmacology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

[3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Migraine therapy: relationship between serotonergic contractile receptors in canine and rabbit saphenous veins to human cerebral and coronary arteries

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Coronary vasospasm induced by subcutaneous sumatriptan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Sumatriptan and chest pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Transmural myocardial infarction with sumatriptan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Effects of S20749, a close analogue of sumatriptan, on porcine carotid haemodynamics and human isolated coronary artery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Naratriptan: biological profile in animal models relevant to migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Cardiorespiratory distress after sumatriptan given by injection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Adverse reactions associated with sumatriptan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Sumatriptan-induced stroke in sagittal sinus thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Subcutaneous sumatriptan during the migraine aura

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

A clinical review of the adaptive role of vasopressin in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

The clinical profile of sumatriptan: safety and tolerability

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Emerging preclinical and clinical profile of 311C90: a poster review and discussion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

Emerging treatments in headache

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_6

10.1007/978-3-0348-8845-5_6

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949863%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference